Uncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17

Area of Science:

• Smooth muscle physiology
• Molecular mechanisms of contraction
• Cell signaling pathways

Background:

• Smooth muscle contraction is regulated by myosin light chain phosphatase (MLCP) activity.
• MLCP inhibition, via RhoA/Rho kinase (ROK) or CPI-17, increases Ca2+-sensitized force.
• Investigating the interplay between these inhibition mechanisms is key.

Purpose of the Study:

• To explore the crosstalk between RhoA/ROK and CPI-17 pathways in MLCP inhibition.
• To elucidate the role of CPI-17 in smooth muscle Ca2+-sensitization using a natural knockout model.

Main Methods:

• Utilized chicken amnion smooth muscle, a natural CPI-17 knockout.
• Stimulated smooth muscle with GTPgammaS, U46619, carbachol, and phorbol ester.
• Assessed Ca2+-sensitized force, RhoA activation, and MYPT-1 phosphorylation.

Main Results:

• GTPgammaS induced Ca2+-sensitized force, while U46619, carbachol, and phorbol ester did not in the absence of CPI-17.
• Recombinant CPI-17 rescued the force response to U46619, carbachol, and phorbol ester.
• U46619 increased GTP.RhoA only in the presence of CPI-17; MYPT-1 phosphorylation at T850 increased with GTPgammaS.

Conclusions:

• CPI-17 plays a critical role in mediating Ca2+-sensitized force in response to certain agonists.
• CPI-17 may act upstream of RhoA activation, potentially by engaging another PP1 family member.
• This suggests a complex regulatory network controlling smooth muscle contraction.